NMR, ESR, EPR, MRI....
Applications for this prestigious award are invited by 30 November 2018.
Bruker have introduced a new workflow for phenomics research and validation, where MS is complementary to NMR, using flow injection analysis-magnetic resonance mass spectrometry (FIA-MRMS). FIA-MRMS can generate molecular formulae for >1000 medium level metabolites, and reveals new metabolites not seen in LC-MS, e.g. polar compounds. With MetaboScape™ software, high confidence metabolite annotation is based on MRMS extreme mass resolution >1 million and mass accuracy ~0.2 ppm.
Bruker’s established IVDr-by-NMR solution for phenomics research is now also being offered for biobanking applications to assess sample quality with rigorous SOPs. It can provide reliable, quantitative data on 150 metabolic biomarkers in urine in a single experiment under full automation, with high throughput and at low cost per sample.